These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3527577)

  • 1. Production and release of cloacin DF13 and related colicins.
    De Graaf FK; Oudega B
    Curr Top Microbiol Immunol; 1986; 125():183-205. PubMed ID: 3527577
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of divalent cations and of phospholipase A activity on excretion of cloacin DF13 and lysis of host cells.
    Luirink J; van der Sande C; Tommassen J; Veltkamp E; De Graaf FK; Oudega B
    J Gen Microbiol; 1986 Mar; 132(3):825-34. PubMed ID: 3016150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colicins are not transiently accumulated in the periplasmic space before release from colicinogenic cells.
    Cavard D; Bernadac A; Pages JM; Lazdunski C
    Biol Cell; 1984; 51(1):79-86. PubMed ID: 6237702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncoupling of synthesis and release of cloacin DF13 and its immunity protein by Escherichia coli.
    Luirink J; de Graaf FK; Oudega B
    Mol Gen Genet; 1987 Jan; 206(1):126-32. PubMed ID: 3553860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein H encoded by plasmid CloDF13 is involved in excretion of cloacin DF13.
    Oudega B; Stegehuis F; van Tiel-Menkveld GJ; de Graaf FK
    J Bacteriol; 1982 Jun; 150(3):1115-21. PubMed ID: 6281236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular structure of the immunity gene and immunity protein of the bacteriocinogenic plasmid Clo DF13.
    van den Elzen PJ; Gaastra W; Spelt CE; de Graaf FK; Veltkamp E; Nijkamp HJ
    Nucleic Acids Res; 1980 Oct; 8(19):4349-63. PubMed ID: 6253914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular structure and immunity specificity of colicin E6, an evolutionary intermediate between E-group colicins and cloacin DF13.
    Akutsu A; Masaki H; Ohta T
    J Bacteriol; 1989 Dec; 171(12):6430-6. PubMed ID: 2687234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 76-residue polypeptide of colicin E9 confers receptor specificity and inhibits the growth of vitamin B12-dependent Escherichia coli 113/3 cells.
    Penfold CN; Garinot-Schneider C; Hemmings AM; Moore GR; Kleanthous C; James R
    Mol Microbiol; 2000 Nov; 38(3):639-49. PubMed ID: 11069686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in protein synthesis on mitomycin C induction of wild-type and mutant CloDF13 plasmids.
    Dougan G; Sherratt DJ
    J Bacteriol; 1977 May; 130(2):846-51. PubMed ID: 233723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and excretion of cloacin DF13 by Escherichia coli harboring plasmid CloDF13.
    Van Tiel-Menkvled GJ; Rezee A; De Graaf FK
    J Bacteriol; 1979 Nov; 140(2):415-23. PubMed ID: 227839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in the carboxy-terminal half of cloacin destabilize the protein and prevent its export by Escherichia coli.
    van Putten AJ; Stegehuis F; van Bergen en Henegouwen PM; De Graaf FK; Oudega B
    Mol Microbiol; 1988 Sep; 2(5):553-62. PubMed ID: 3054421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pCloDF13-encoded bacteriocin release proteins with shortened carboxyl-terminal segments are lipid modified and processed and function in release of cloacin DF13 and apparent host cell lysis.
    Luirink J; Clark DM; Ras J; Verschoor EJ; Stegehuis F; de Graaf FK; Oudega B
    J Bacteriol; 1989 May; 171(5):2673-9. PubMed ID: 2651413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mode of action of the cloacin DF13-immunity protein.
    Oudega B; Klaasen-Boor P; De Graaf FK
    Biochim Biophys Acta; 1975 May; 392(1):184-95. PubMed ID: 1092372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of cloacin DF13 by susceptible cells: removal of immunity protein and fragmentation of cloacin molecules.
    Krone WJ; de Vries P; Koningstein G; de Jonge AJ; de Graaf FK; Oudega B
    J Bacteriol; 1986 Apr; 166(1):260-8. PubMed ID: 2420782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The stable bacteriocin release protein signal peptide, expressed as a separate entity, functions in the release of cloacin DF13.
    van der Wal FJ; ten Hagen CM; Oudega B; Luirink J
    FEMS Microbiol Lett; 1995 Sep; 131(2):173-7. PubMed ID: 7557327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excretion of proteins by gram-negative bacteria: export of bacteriocins and fimbrial proteins by Escherichia coli.
    Oudega B; Mooi FR; de Graaf FK
    Antonie Van Leeuwenhoek; 1984; 50(5-6):569-84. PubMed ID: 6152145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a mutation preventing lipid modification on localization of the pCloDF13-encoded bacteriocin release protein and on release of cloacin DF13.
    Luirink J; Hayashi S; Wu HC; Kater MM; de Graaf FK; Oudega B
    J Bacteriol; 1988 Sep; 170(9):4153-60. PubMed ID: 3045086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replication and structure of the bacteriocinogenic plasmids Clo DF13 and CoI E1.
    Veltkamp E; Stuitje AR
    Plasmid; 1981 Jan; 5(1):76-99. PubMed ID: 6164067
    [No Abstract]   [Full Text] [Related]  

  • 19. Bacteriocinogenic Clo DF13 minicells of Escherichia coli synthesize a protein that accounts for immunity to bacteriocin Clo DF16: action of the immunity protein in vivo and in vitro.
    Kool AJ; Borstlap AJ; Nijkamp HJ
    Antimicrob Agents Chemother; 1975 Jul; 8(1):76-85. PubMed ID: 1099984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. tolQ is required for cloacin DF13 susceptibility in Escherichia coli expressing the aerobactin/cloacin DF13 receptor IutA.
    Thomas JA; Valvano MA
    FEMS Microbiol Lett; 1992 Mar; 70(2):107-11. PubMed ID: 1587457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.